Ionized Magnesium for Monitoring of Citrate-anticoagulated CVVHD

  • STATUS
    Recruiting
  • participants needed
    40
  • sponsor
    University Hospital, Montpellier
Send
Updated on 16 February 2024
See if I qualify
dialysis
hypomagnesemia
continuous renal replacement therapy
ionized magnesium

Summary

It has been reported in several studies that ionized hypomagnesemia is associated with higher morbidity and mortality rates. During continuous renal replacement therapy with regional citrate anticoagulation (CRRT-RCA), the loss of magnesium has been reported to not be covered by magnesium concentration in ordinary dialysis fluid. This may lead to ionized hypomagnesemia. However the incidence of ionized hypomagnesemia in patients requiring CRRT-RCA remains unclear and need to be estimated to determine if ionized magnesium monitoring could be of interest. This study aim to assess the incidence of ionized hypomagnesemia induced by CRRT-RCA.

Details
Condition Intensive Care Unit Syndrome
Age 18years - 100years
Clinical Study IdentifierNCT04412980
SponsorUniversity Hospital, Montpellier
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Consecutive patients admitted to the ICU and requiring continuous renal replacement therapy with regional citrate anticoagulation
age > 18 ans

Exclusion Criteria

Persons under protection
Paritcipation rejections
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

dialysis
hypomagnesemia
continuous renal replacement therapy
ionized magnesium

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.